Blood Cancer Treatment Could Age Immune Cells By As Much As 30 Years
The use of autologous stem cell transplants to treat blood cancer may age patients’ immune cells by up to 30 years, a new study indicates. Researchers in the US found clues that suggest the treatment, which relies on a patient’s own stem cells, leads to a